This website uses cookies

We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will only use cookies based on your decision.

EMIT 2000 Tacrolimus Assay

Monitoring tacrolimus levels is essential to ensuring efficacy of treatment while minimizing toxic side effects and preventing organ rejection. The EMIT® 2000 tacrolimus method is a convenient, easy to use solution for routine tacrolimus monitoring.

Features

  • Simple sample pretreatment
  • Results in as little as 10 minutes
  • No reagent preparation required
  • No significant hematocrit interference 1,2
  • Correlates to LC/MS/MS

Advantages

  • Streamlined ISD monitoring and enhanced productivity
  • Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® Drug Testing System*

 

EMIT 2000 TACR Assay
Product Code
8R019UL
Sample Type
EDTA Whole Blood
Pretreatment
Manual
Reportable Range
2-30 ng/mL
Functional Sensitivity
2.8 ng/mL
Calibration
With new reagent lot
Reagent Stability
Opened at 2-8° C: 12 weeks

Learn more about the V-Twin® and Viva-E® Drug Testing Systems

Enduring Expertise for Your Immunosuppressant Drug Testing Needs

With recognized drug testing expertise, Siemens Healthcare Diagnostics offers a comprehensive and expanding menu of tests across multiple instrument solutions to meet the immunosuppressant drug (ISD) testing needs of customers in any setting.


References
1. Hermida J et al: Clinical Significance of Hematrocrit Interference in the Tacroliums II Microparticle Enzyme Immunoassay: A Tentative Approach. Clin Lab 2005; 51: 43-45.
2. LeGatt, CES: Comparison of Two Tacrolimus Immuno assays (EMIT: Viva and MEIA: IMx®) in Four Transplant Groups. AACC 2002; Topic 19, Presentation B-7.

Subscription Button Icon
Be the first to know about our events, training, and news